Cargando...
Targeting B-cell maturation antigen in multiple myeloma
Novel effective immunotherapies are needed for patients with multiple myeloma (MM), since disease recurrence remains a major obstacle. B-cell maturation antigen (BCMA), a cell surface protein universally expressed on malignant plasma cells , has emerged as a very selective antigen to be targeted in...
Guardado en:
| Publicado en: | Immunotherapy |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Future Medicine Ltd
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4976846/ https://ncbi.nlm.nih.gov/pubmed/26370838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt.15.77 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|